Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y S Tuininga

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Cardiac Failure|July 25, 2000
Electrophysiological changes of angiotensin-converting enzyme inhibition after myocardial infarctionY S Tuininga, A C Wiesfeld, D J van Veldhuisen, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 1, 1994
Restacorin, a new antiarrhythmic drug: a review of its electrophysiologic and hemodynamic propertiesY S Tuininga, H J Crinjns, C Kozma, et al.
American Heart Journal|August 1, 1993
Electrocardiographic patterns relative to initiating mechanisms of exercise-induced ventricular tachycardiaY S Tuininga, H J Crijns, A C Wiesfeld, et al.
British Heart Journal|December 1, 1994
Association between reduced heart rate variability and left ventricular dilatation in patients with a first anterior myocardial infarction. CATS Investigators. Captopril and Thrombolysis StudyJ H Dambrink, Y S Tuininga, W H van Gilst, et al.
British Heart Journal|December 1, 1994
Heart rate variability in left ventricular dysfunction and heart failure: effects and implications of drug treatmentY S Tuininga, D J van Veldhuisen, J Brouwer, et al.
Pacing and Clinical Electrophysiology : PACE|May 1, 1996
Electrophysiological, rate dependent, and autonomic effects of the class III antiarrhythmic almokalant after myocardial infarction in the pigY S Tuininga, C D De Langen, H J Crijns, et al.
American Heart Journal|May 1, 1994
Potential role of endomyocardial biopsy in the clinical characterization of patients with idiopathic ventricular fibrillation: arrhythmogenic right ventricular dysplasia--an undervalued causeA C Wiesfeld, H J Crijns, R B Van Dijk, et al.
Circulation|December 15, 1995
Evaluation of importance of central effects of atenolol and metoprolol measured by heart rate variability during mental performance tasks, physical exercise, and daily life in stable postinfarct patientsY S Tuininga, H J Crijns, J Brouwer, et al.
Journal of Cardiovascular Pharmacology|March 1, 1994
Hemodynamic effects of the new antiarrhythmic agent restacorin in patients with normal and decreased left ventricular functionY S Tuininga, H J Crijns, B Oosterhuis, et al.
Journal of Cardiovascular Pharmacology|January 1, 1995
Exploratory study of the effects of single doses of isomazole on hemodynamics and heart rate variability parameters in chronic heart failureY S Tuininga, D J van Veldhuisen, H J Crijns, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Cardiac Failure|July 25, 2000
Electrophysiological changes of angiotensin-converting enzyme inhibition after myocardial infarctionY S Tuininga, A C Wiesfeld, D J van Veldhuisen, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 1, 1994
Restacorin, a new antiarrhythmic drug: a review of its electrophysiologic and hemodynamic propertiesY S Tuininga, H J Crinjns, C Kozma, et al.
American Heart Journal|August 1, 1993
Electrocardiographic patterns relative to initiating mechanisms of exercise-induced ventricular tachycardiaY S Tuininga, H J Crijns, A C Wiesfeld, et al.
British Heart Journal|December 1, 1994
Association between reduced heart rate variability and left ventricular dilatation in patients with a first anterior myocardial infarction. CATS Investigators. Captopril and Thrombolysis StudyJ H Dambrink, Y S Tuininga, W H van Gilst, et al.
British Heart Journal|December 1, 1994
Heart rate variability in left ventricular dysfunction and heart failure: effects and implications of drug treatmentY S Tuininga, D J van Veldhuisen, J Brouwer, et al.
Pacing and Clinical Electrophysiology : PACE|May 1, 1996
Electrophysiological, rate dependent, and autonomic effects of the class III antiarrhythmic almokalant after myocardial infarction in the pigY S Tuininga, C D De Langen, H J Crijns, et al.
American Heart Journal|May 1, 1994
Potential role of endomyocardial biopsy in the clinical characterization of patients with idiopathic ventricular fibrillation: arrhythmogenic right ventricular dysplasia--an undervalued causeA C Wiesfeld, H J Crijns, R B Van Dijk, et al.
Circulation|December 15, 1995
Evaluation of importance of central effects of atenolol and metoprolol measured by heart rate variability during mental performance tasks, physical exercise, and daily life in stable postinfarct patientsY S Tuininga, H J Crijns, J Brouwer, et al.
Journal of Cardiovascular Pharmacology|March 1, 1994
Hemodynamic effects of the new antiarrhythmic agent restacorin in patients with normal and decreased left ventricular functionY S Tuininga, H J Crijns, B Oosterhuis, et al.
Journal of Cardiovascular Pharmacology|January 1, 1995
Exploratory study of the effects of single doses of isomazole on hemodynamics and heart rate variability parameters in chronic heart failureY S Tuininga, D J van Veldhuisen, H J Crijns, et al.
Pageof 3